Artal Group S.A. Moderna, Inc. Transaction History

Artal Group S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $5.46 Million - $9.3 Million	-50,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $16.4 Million - $42.5 Million	-250,000 Reduced 83.33%	50,000 $5.22 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $10.9 Million - $19 Million	-200,000 Reduced 40.0%	300,000 $21.2 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $74.2 Million - $200 Million	-2,500,000 Reduced 83.33%	500,000 $32.1 Million
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $28.6 Million - $50.7 Million	-1,606,298 Reduced 34.87%	3,000,000 $89.9 Million
Q2 2019 Aug 09, 2019	SELL	$13.7 - $28.34 $5.48 Million - $11.3 Million	-400,000 Reduced 7.99%	4,606,298 $67.4 Million
Q1 2019 May 10, 2019	SELL	$14.45 - $23.7 $3.61 Million - $5.93 Million	-250,000 Reduced 4.76%	5,006,298 $102 Million
Q4 2018 Feb 11, 2019	BUY	$13.52 - $18.8 $71.1 Million - $98.8 Million	5,256,298 New	5,256,298 $80.3 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.